Liu, C., Lou, W., Zhu, Y., Yang, J. C., Nadiminty, N., Gaikwad, N. W., . . . Gao, A. C. (2015). Intracrine androgens and AKR1C3 activation confer resistance to enzalutamide in prostate cancer. Cancer Res.

Liu, Chengfei, Wei Lou, Yezi Zhu, Joy C. Yang, Nagalakshmi Nadiminty, Nilesh W. Gaikwad, Christopher P. Evans, και Allen C. Gao. "Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer." Cancer Res 2015.

Liu, Chengfei, et al. "Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer." Cancer Res 2015.